Verge Genomics
We use human data and AI to develop better drugs faster.
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms. Verge Genomics is a Y Combinator company (Summer 2015). YC-listed status: Active.
- Website
- vergelabs.com
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Verge Labs — AI drug discovery platform for neuroscience using multimodal patient brain data to identify targets, stratify patients, and shrink clinical trial size. · Service · Enterprise
Links
- Y Combinator profileycombinator